EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach

Mohd Imran, Abida, Nawaf M Alotaibi, Hamdy Khamees Thabet, Jamal Alhameedi Alruwaili, Syed Mohammed Basheeruddin Asdaq, Lina Eltaib, Mehnaz Kamal, Amal Bader Hommod Alshammari, Abdulmajeed Mohammed Abdullah Alshammari, Ahmed Alshehri

Journal of Infection and Public Health · 2023-04 · 16 (4) · 554-572

DOI: 10.1016/j.jiph.2023.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2023-04. Verfasst von Mohd Imran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia. Electronic address: mohammad.baks…. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Northern Border University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The emergence of various drug-resistant strains of Mycobacterium tuberculosis compelled medicinal chemists to expedite the discovery of novel, safer alternatives to present regimens. Decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1), an essential component of arabinogalactan biosynthesis, has been considered a novel target for developing new inhibitors against Tuberculosis. We aimed to discover DprE1 inhibitors utilizing the drug repurposing approach. METHODS: A structure-based virtual screening of FDA and world-approved drugs database was carried out, and initially, 30 molecules were selected based on their binding affinity. These compounds were further analyzed by molecular docking with extra-precision mode, MMGBSA binding free energy estimation, and prediction of ADMET profile. RESULTS: Based on the docking results and MMGBSA energy values- ZINC000006716957, ZINC000011677911, and ZINC000022448696 were identified to be the top three hit molecules with good binding interactions inside the active site of DprE1. These hit molecules were subjected to molecular dynamics (MD) simulation for a period of 100 ns to study the dynamic nature of the binding complex. MD results were in accordance with molecular docking and MMGBSA analysis showing protein-ligand contacts with key amino acid residues of DprE1. CONCLUSION: Based on their stability throughout the 100 ns simulation, ZINC000011677911 was the best in silico hit with an already known safety profile. This molecule could lead to future optimization and development of new DprE1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsMycobacterium tuberculosisHumansMolecular Docking SimulationDrug RepositioningMolecular Dynamics SimulationComputers

Stichwörter der Autor:innen

Computer-aided drug designDockingDprE1 inhibitorsDrug repurposingMolecular DynamicsVirtual screening

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia. Electronic address: mohammad.baks@nbu.edu.sa.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia. Electronic address: abeda.mohammed@nbu.edu.sa.
  • Department of Clinical Pharmacy, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia. Electronic address: nawaf.al-otaibi@nbu.edu.sa.
  • Chemistry Department, Faculty of Arts and Science, Northern Border University, Rafha 91911, Saudi Arabia. Electronic address: hamdy.salem@nbu.edu.sa.
  • College of Applied Medical Sciences, Medical Lab Technology Department, Northern Border University, Arar 91431, Saudi Arabia. Electronic address: Jamal.alruwaili@nbu.edu.sa.
  • Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, Riyadh 13713, Saudi Arabia. Electronic address: sasdaq@gmail.com.

Förderung

  • Northern Border University

Zitieren

APA

Imran, M., Abida, Alotaibi, N. M., Thabet, H. K., Alruwaili, J. A., Asdaq, S. M. B., Eltaib, L., Kamal, M., Alshammari, A. B. H., Alshammari, A. M. A., & Alshehri, A. (2023). Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach. Journal of Infection and Public Health, 16(4), 554-572. https://doi.org/10.1016/j.jiph.2023.02.005

Vancouver

Imran M, Abida, Alotaibi NM, Thabet HK, Alruwaili JA, Asdaq SMB, et al. Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach. Journal of Infection and Public Health. 2023;16(4):554-572. doi:10.1016/j.jiph.2023.02.005

BibTeX
@article{Imran2023,
  author = {Imran, Mohd and Abida and Alotaibi, Nawaf M and Thabet, Hamdy Khamees and Alruwaili, Jamal Alhameedi and Asdaq, Syed Mohammed Basheeruddin and Eltaib, Lina and Kamal, Mehnaz and Alshammari, Amal Bader Hommod and Alshammari, Abdulmajeed Mohammed Abdullah and Alshehri, Ahmed},
  title = {Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach},
  journal = {Journal of Infection and Public Health},
  year = {2023},
  volume = {16},
  number = {4},
  pages = {554--572},
  doi = {10.1016/j.jiph.2023.02.005}
}
Kostenlos starten →